Kang Ren

Kang Ren is the founder and CEO of GYENNO Science (臻络科学), a company applying AI to Parkinson's disease — per a Qiming Venture Partners interview published in April 2025, his academic background "laid the foundation for GYENNO's distinctive DNA," and he has been interviewed by China News Service about using AI to cut through the "thousand faces, thousand cases" fog of Parkinson's . Beyond that, elsewhere's corpus has no substantive coverage of him — the other material in this result set is about unrelated AI founders and investors and says nothing about Kang Ren himself.